SavedAdd your journal

Journals / Anadolu Psikiyatri Dergisi / 2019 / Cilt: 20 - Sayı: 3

Comparison of clinical features, comorbidity and functioning in substance dependents with and without adult ADHD

Erişkin DEHB olan ve olmayan madde bağımlılarında klinik özellikler, eş tanı ve işlevselliğin karşılaştırılması

Esin ERDOĞAN
Dursun Hakan DELİBAŞ
Pages
296–304
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In adults, there is a need for randomized, longitudinal follow-up studies involving both genders, investigating the effect of ADHD on SUD. (Anatolian Journal of Psychiatry 2019; 20(3):296-304)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Because of the interrelation between attention deficit hyperactivity disorder (ADHD) and substance use disorders (SUD), clinicians should consider ADHD comorbidity in assessment and treatment phase when evaluating adult substance dependence.
📊
Key Findings & Data:Methods: 226 patients with substance dependence were included in the study (ADHD-=140, ADHD+=86).
💡
Conclusion & Impact:In adults, there is a need for randomized, longitudinal follow-up studies involving both genders, investigating the effect of ADHD on SUD. (Anatolian Journal of Psychiatry 2019; 20(3):296-304)
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Because of the interrelation between attention deficit hyperactivity disorder (ADHD) and substance use disorders (SUD), clinicians should consider ADHD comorbidity in assessment and treatment phase when evaluating adult substance dependence. It was aimed to compare the adult substance dependent patients with comorbid ADHD (ADHD+) and without comorbid ADHD (ADHD-) in terms of clinical features, psychiatric comorbidity and de- gree of functioning. Methods: 226 patients with substance dependence were included in the study (ADHD-=140, ADHD+=86). Diagnostic interview with SCID-I was performed. Adult ADD/ADHD DSM IV-Based Diagnostic Screening and Rating Scale, Wender Utah Rating Scale, Barratt Impulsivity Scale-11, Personal and Social Perfor- mance Scale were applied. ADHD+ and ADHD- groups were compared in terms of clinical features of substance dependence, psychiatric comorbidity and scale outcomes. Results: The group of ADHD+ was starting using sub- stance at an earlier age. Polysubstance use, number of days of substance use, and legal issues related to the sub- stance were higher than the ADHD- group. ADHD+ group had more stimulant, opiate dependency. Rates of suicidal ideation and attempts, psychiatric comorbidity were higher in ADHD+ group. Personal and social functioning of ADHD+ group was worse. Discussion: ADHD+ group differs from the ADHD- group in terms of the clinical char- acteristics associated with the substance. In adults, there is a need for randomized, longitudinal follow-up studies involving both genders, investigating the effect of ADHD on SUD. (Anatolian Journal of Psychiatry 2019; 20(3):296-304)

Özet

Amaç: Dikkat eksikliği hiperaktivite bozukluğu (DEHB) ve madde kullanım bozuklukları (MKB) arasındaki karşılıklıilişki nedeniyle klinisyenler, erişkin madde bağımlılarını değerlendirirken DEHB eş tanısını, değerlendirme ve tedaviaşamasında dikkate almalıdır. Bu araştırmada DEHB eş tanısı olan (DEHB+) ve olmayan (DEHB-) erişkin maddebağımlılarının klinik özellikleri, psikiyatrik eş tanıları ve işlevsellik düzeyi bakımından karşılaştırılması amaçlan-mıştır. Yöntem: Çalışmaya 226 madde bağımlısı erkek hasta alındı (DEHB-=140, DEHB+=86). SCID-I ile tanısalgörüşme yapıldı. Erişkin Dikkat Eksikliği Hiperaktivite Bozukluğu Ölçeği, Wender Utah Derecelendirme Ölçeği,Barratt İmpulsivite Ölçeği-11, Bireysel ve Sosyal Performans Ölçeği uygulandı. DEHB+ ve DEHB- gruplar maddebağımlılığının klinik özellikleri, psikiyatrik eş tanıları ve ölçek sonuçları açısından karşılaştırıldı. Sonuçlar: DEHB+olan grup maddeye daha erken yaşta başlıyordu. DEHB- gruba göre çoğul madde kullanımı, madde kullanılan günsayısı, maddeyle ilişkili yasal sorunlar daha yüksekti. DEHB+ grupta stimülan ve opiat bağımlılığı daha fazlaydı.Özkıyım düşüncesi ve girişimi, psikiyatrik eş tanı oranı DEHB+ grupta daha fazlaydı. DEHB+ grubun bireysel vesosyal işlevselliği daha kötüydü. Tartışma: DEHB+ grup maddeyle ilişkili klinik özellikleri açısından DEHB- grubagöre farklılık göstermektedir. Erişkinlerde DEHB’nin MKB üzerine etkisini araştıran, her iki cinsiyeti de kapsayan,randomize, uzunlamasına izlem çalışmalarına gerek vardır. (Anadolu Psikiyatri Derg 2019; 20(3):296-304)

🔖

Cite This Article

ERDOĞAN, E., DELİBAŞ, D. H. (2019). Comparison of clinical features, comorbidity and functioning in substance dependents with and without adult ADHD. Anadolu Psikiyatri Dergisi, Cilt: 20 - Sayı: 3, 296–304. https://ajindex.com/articles/356286

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Klein RG, Mannuzza S, Olazagasti MAR, Roizen E, Hutchison JA, Lashua EC, et al. Clinical and functional outcome of childhood attention-deficit/ hyperactivity disorder 33 years later. Arch Gen Psychiatry 2012; 69(Suppl.12):1295. Biederman J. Attention-deficit/hyperactivity disorder: A selective overview. Biol Psychiatry 2005; 57(Suppl.11):1215-1220.
  2. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, et al. Attention-deficit/ hyper- activity disorder in adults: An overview. Biol Psychiatry 2000; 48(Suppl.1):9-20.
  3. Wilson JJ, Levin FR. Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol 2005; 15:751- 763. Satterfield JH, Faller KJ, Crinella FM, Schell AM, Swanson JM, Homer LD. A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality. J Am Acad Child Adolesc Psychiatry 2007; 46:601-610. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 2004; 27(Suppl.2):283-301.
  4. Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998; 52(Suppl.1):15-25. van Emmerik-van Oortmerssen K, van de Glind G, Koeter MWJ, Allsop S, Auriacombe M, Barta C, et al. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction 2014; 109(Suppl.2):262-272.
  5. Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, et al. Correlates of co-occurring ADHD in drug-dependent subjects: Prevalence and features of substance dependence and psychiatric disorders. Addict Behav 2008; 33(Suppl.9):1199-1207.
  6. Wilens TE, Martelon M, Joshi G, Bateman C, Fried R, Petty C, et al. Does ADHD predict sub-stance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatry 2011; 50(Suppl.6):543-553.
  7. Chang Z, Lichtenstein P, Larsson H. The effects of childhood ADHD symptoms on early-onset sub-stance use: A Swedish twin study. J Abnorm Child Psychol 2012; 40(Suppl.3):425-435.
  8. Yule AM, Martleon M, Faraone S, Carrellas N, Wilens T E, Biederman J. Examining the associa-tion between attention deficit hyperactivity disor-der and substance use disorders: a familial risk analysis. J Psychiatr Res 2017; (85):49-55).
  9. McCabe SE, Dick